PAREXEL has entered into a definitive agreement to acquire ExecuPharm, Inc., a global functional service provider (FSP) serving the biopharma industry. Financial terms were not disclosed. The acquisition is expected to close in the next three weeks.    Headquartered in King of Prussia, PA, ExecuPharm provides qualified professionals across functional areas, such as clinical monitoring or study management, along with associated operational activities including onboarding, training, line managem...